Smart & Biggar announced today that the firm has been named one of Canada's Top 100 Employers, in the Small Medium Enterprise (SME) category. This special designation recognizes employers in Canada with under 500 employees, that lead their industries in offering an exceptional employee experience and workplace environm
On Wednesday, March 21st Smart & Biggar will be hosting “Branding for CEO’s”, an IP Masterclass at Bayview Yards in partnership with Invest Ottawa. Attendees are invited to join Daniel Anthony and Andrea Kroetch, from the firm’s Ottawa office, as they discuss how to leverage trademarks to drive business advantage.
Graham Hood, Associate in Smart & Biggar’s Toronto office, will be leading a seminar at the Ryerson Communication & Design Conference on Saturday March 3, 2018. Graham will be speaking to aspiring creative professionals on the importance of protecting their work.
Smart & Biggar is proud to sponsor the C5’s Pharma & Biotech Patent Litigation Conference in Amsterdam, Netherlands. Now in its 10th year, the conference explores the complex and continually contentious legal landscape of patent litigation in the pharma and biotech sphere.
Smart & Biggar is honoured to support The Harold G. Fox Moot on February 23 -24, 2018. Firm partner Sheldon Hamilton will be attending as a panelist.
by: Andrea Kroetch and Sebastian Beck-Watt
Trademark laws in Canada will soon be changing, and among these will be an expanded definition of “trademark”, which will now include the possibility of protecting colour per se as a trademark (as opposed to colour applied to a product having a particular shape). Rights ow
by: Kevin P. Siu
What happens when a patentee is unsuccessful in a prohibition application under the Patented Medicines (Notice of Compliance) (PMNOC) Regulations against a generic entrant, but subsequently prevails in an infringement action on the same patent? Can it be liable for section 8 damages under the Reg
by: Katie Lee and Urszula Wojtyra
On March 7, 2018, the Federal Court upheld the validity of Kennedy’s patent for a use of infliximab (Janssen’s REMICADE) (Patent No. 2,261,630 [the “630 patent”]), and granted Kennedy’s counterclaim that Hospira’s biosimilar INFLECTRA infringed the 630 patent: Hospira Healthcare C
by: Andrew Mandlsohn
On March 20, 2018, the Federal Court of Appeal (FCA) issued public reasons for judgment dismissing Eli Lilly Canada Inc. (Lilly)’s appeal of a Federal Court decision awarding more than $70 million to Teva Canada Limited (Teva) under section 8 of the Patented Medicines (Notice of Compliance) (
by Jeremy E. Want and Daniel S. Davies
The Canadian “accounting of profits” remedy for patent infringement, which is not available in the U.S., provides a potentially significant opportunity for companies with Canadian IP rights.
Recent court decisions have highlighted the potential advantages of the accounting
Smart & Biggar confirms its position as a leader in IP law across Canada in the most recent edition of the Canadian Legal Lexpert Directory.
Smart & Biggar is proud to have been honoured with a record-setting five (5) prestigious awards by Managing Intellectual Property (MIP). The firm has long been recognized by MIP as a leader in IP, and this year was the only Canadian firm to be nominated across all categories.
Smart & Biggar is pleased to announce that the firm has once again earned the top ranking as a Tier One firm in the areas of patent contentious and patent prosecution in Managing Intellectual Property's 2018 IP Stars Handbook: Patents. This is the fifth consecutive year that Smart & Biggar has been recognized at the hi
Smart & Biggar announced today that eleven of the firm’s partners have been recognized in the 2018 World IP Review Leaders, a comprehensive guide to the top intellectual property lawyers in the areas of patents and trademarks across the globe.
Smart & Biggar, Canada’s largest law firm practising exclusively in intellectual property and technology, announced today that it has been named the “Canadian IP Litigation Firm of the Year” by Benchmark Canada for the fourth consecutive year. The Benchmark Canada Awards event was held in Toronto on February 22nd to re